<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>MODERN ADVANCES IN THE STUDY OF HUMORAL AND CELLULAR IMMUNITY IN CHILDREN BORN FROM A MOTHER WITH COVID-19.</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Karomatova Fazolat</mods:namePart><mods:namePart type="family">Abdikaxxorovna</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Although several studies have provided information on short-term clinical outcomes in children with perinatal exposure to SARS-CoV-2, data on the immune response in the first months of life among newborns exposed to the virus in utero are lacking. The purpose of the study to characterize systemic and mucosal antibody production during the first 2 months of life among infants who were born to mothers infected with SARS-CoV-2.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2024-04-14</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Center for Tech and Media Research</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>